Citigroup’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Sell |
3,474
-57,597
| -94% | -$334K | ﹤0.01% | 4347 |
|
|
2025
Q1 | $172K | Buy |
61,071
+569
| +0.9% | +$1.61K | ﹤0.01% | 3518 |
|
|
2024
Q4 | $416K | Buy |
60,502
+2,169
| +4% | +$14.9K | ﹤0.01% | 3145 |
|
|
2024
Q3 | $1.06M | Hold |
58,333
| – | – | ﹤0.01% | 2522 |
|
|
2024
Q2 | $1.11M | Hold |
58,333
| – | – | ﹤0.01% | 2188 |
|
|
2024
Q1 | $1.26M | Hold |
58,333
| – | – | ﹤0.01% | 2193 |
|
|
2023
Q4 | $1.01M | Hold |
58,333
| – | – | ﹤0.01% | 2139 |
|
|
2023
Q3 | $573K | Hold |
58,333
| – | – | ﹤0.01% | 2317 |
|
|
2023
Q2 | $321K | Hold |
58,333
| – | – | ﹤0.01% | 2995 |
|
|
2023
Q1 | $362K | Hold |
58,333
| – | – | ﹤0.01% | 2754 |
|
|
2022
Q4 | $890K | Hold |
58,333
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q3 | $576K | Hold |
58,333
| – | – | ﹤0.01% | 2495 |
|
|
2022
Q2 | $691K | Hold |
58,333
| – | – | ﹤0.01% | 2367 |
|
|
2022
Q1 | $1.11M | Hold |
58,333
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q4 | $1.37M | Buy |
+58,333
| New | +$1.37M | ﹤0.01% | 2261 |
|